Patterns of care and outcomes for endometrial and ovarian cancers in botswana 2015–2021

Bibliographic Details
Title: Patterns of care and outcomes for endometrial and ovarian cancers in botswana 2015–2021
Authors: Christian Lumley, Samantha Batman, Lisa Bazzett-Matabele, Barati Monare, Memory Bvochora-Nsingo, Sebathu Chiyapo, Rebecca Ketlametswe, Gaborone Mbulawa, Alexander Seiphetlheng, Gaobakwe Ramontshonyane, Tlotlo Ralefala, Rebecca Luckett, Peter Vuylsteke, Surbhi Grover
Source: Gynecologic Oncology Reports, Vol 49, Iss , Pp 101262- (2023)
Publisher Information: Elsevier, 2023.
Publication Year: 2023
Collection: LCC:Gynecology and obstetrics
LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Endometrial neoplasms, Ovarian neoplasms, Survival analysis, Botswana, Gynecology and obstetrics, RG1-991, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Purpose: Endometrial and ovarian cancers are leading causes of cancer death among women. However, there is little data on these patients from low- and middle-income countries including Botswana, a country in sub-Saharan Africa. This study reports data on demographics, treatment, and outcomes for patients with endometrial and ovarian cancer in Botswana. Methods: This prospective cohort study included all prospectively enrolled patients with endometrial or ovarian cancer who presented to Princess Marina or Gaborone Private Hospital between May 2015 and May 2021. Demographic, treatment, and survival data were analyzed. Results: 99 patients with endometrial and 38 patients with ovarian cancer were included. Median age at diagnosis was 64 for patients with endometrial cancer and 57 for patients with ovarian cancer. Just over half of patients with endometrial cancer (52.6%) presented with FIGO stages I and II, whereas most patients with ovarian cancer (65.8%) presented with stages III and IV. 24.2% of patients with endometrial cancer received chemotherapy, 32.3% received radiotherapy, 74.7% received surgical treatment, and 16.2% received no treatment; of patients with ovarian cancer, 42.1% received chemotherapy, 2.6% received radiotherapy, 52.6% received surgical treatment, and 31.6% of patients received no treatment. 1-and 2-year overall survival probabilities were 76.9% and 59.7% for patients with endometrial cancer and 62.8% and 43.7% for patients with ovarian cancer, respectively. Conclusion: This study demonstrates that a large proportion of patients with ovarian and endometrial cancer in Botswana are diagnosed at an advanced stage, and many do not receive standard-of-care treatment. Further inquiry is required to characterize challenges to diagnosis and treatment of ovarian and endometrial cancers in Botswana.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2352-5789
Relation: http://www.sciencedirect.com/science/article/pii/S2352578923001315; https://doaj.org/toc/2352-5789
DOI: 10.1016/j.gore.2023.101262
Access URL: https://doaj.org/article/12d9db9b24354bd4984960b11d798579
Accession Number: edsdoj.12d9db9b24354bd4984960b11d798579
Database: Directory of Open Access Journals
More Details
ISSN:23525789
DOI:10.1016/j.gore.2023.101262
Published in:Gynecologic Oncology Reports
Language:English